EUCTR2009-013777-17-GBActive, not recruitingPhase 1
The effect of pamidronate treatment on bone health in patients with neuromuscular disease undergoing hip surgery. - Using pamidronate in patients with CP undergoing hip surgery.
Central Manchester and Manchester University Children's Hospital NHS Trust.0 sites12 target enrollmentStarted: March 17, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 12
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
Inclusion Criteria
- •All children with neuromuscular conditions between ages 6 and 16 undergoing hip surgery and post-op immobilisation in a hip spica at Royal Manchester Children's Hospital.
- •Exclusion criteria: Failure at screening. Not willing to participate in the study.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
Effect of pamidronate on bone loss and implant stability after total hip arthroplastyPeriprosthetic bone loss after total hip replacementMusculoskeletal DiseasesPeriprosthetic bone lossISRCTN37786144Arthritis Research Campaign (ARC) (UK)
Completed
Phase 4
Effect of bisphosphonate on osteoporosis in kidney transplant patientskidney transplant patients with low bone mineral density.Kidney transplant statusIRCT138804162109N1Ahvaz Jundishapur University of Medical Sciences40
Completed
Not Applicable
Efficacy of pamidronate for adult osteogenesis imperfecta: uncontrolled study.Osteogenesis imperfectaJPRN-UMIN000031290Kobe University Hospital10
Completed
Phase 4
A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.Bone LossNCT00738257Novartis Pharmaceuticals126
Completed
Phase 2
Effect of Pamidronate on treatment of bone painsCondition 1: Bone pains in Cancer patients with bone metastases. Condition 2: Hypercalcemia in Cancer patients with bone metastases. Condition 3: Quality of life in Cancer patients with bone metastases.Secondary malignant neoplasm of bone and bone marrowDisorders of calcium metabolismLifestyle-related conditionIRCT2013032212197N5Vice chancellor for research of Tonekabon Islamic Azad University41